Kulumbegov, B. et al. 2023. Type I and Type IIb Autoimmunity in Chronic Spontaneous Urticaria Patients: Evaluating the Clinical Response to Omalizumab. Georgian Scientists. 5, 2 (May 2023), 109–116. DOI:https://doi.org/10.52340/gs.2023.05.02.14.